Today: 8 February 2026
Subscribe
Browse Category

Financial Forecasts News 20 December 2025

Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston Holdings, Inc. (NYSE: LW) is back in the market’s spotlight this weekend—and not because investors suddenly stopped liking French fries. After reporting second-quarter fiscal 2026 results that beat Wall Street expectations on revenue and adjusted earnings, Lamb Weston shares still fell sharply as investors zeroed in on what management said comes next: continued discounting, unfavorable price/mix, and higher international manufacturing costs that could keep profitability under pressure into the back half of the year. Barron’s+2Reuters+2 Below is what actually happened, what the company guided for fiscal 2026, and how analysts and market watchers are framing the bull case
20 December 2025
···
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine, Inc. (NASDAQ: IRON) stock is seeing a classic “biotech catalyst storm” on Dec. 20, 2025: big intraday swings, headline-driven volatility, and analysts arguing over whether the market is repricing risk or merely repricing uncertainty. As of the latest trading data available, IRON was around $80.04, down roughly 11.5% versus the prior close, after trading as high as $94.60 and as low as $71.46 on heavy volume (about 4.22 million shares). The immediate trigger: a report-driven debate about the FDA’s new fast-track voucher process and whether Disc’s lead drug candidate, bitopertin, remains on the clean, accelerated path bulls were
20 December 2025
·
Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Dec. 20, 2025 — Eli Lilly and Company (NYSE: LLY) is closing out 2025 with momentum—and with fresh headlines that underscore why Eli Lilly stock has become one of the market’s most closely watched healthcare names. Shares last closed at $1,071.44 (Dec. 19) after trading between $1,059.01 and $1,075.38, keeping the stock within reach of its recent highs. Stock Analysis The bigger story isn’t just the price. Lilly entered the rarefied “$1 trillion market value” club this year—an inflection point for a pharmaceutical company—and it’s doing so on the back of a rapidly expanding obesity and cardiometabolic franchise, a pipeline
20 December 2025
···
BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ended Friday’s session sharply higher after announcing a blockbuster rare-disease acquisition that immediately reframed the company’s growth story. Shares closed at $61.15, up about 17.7% on the day, with trading volume far above typical levels—classic “big-news repricing” behavior. Yahoo Finance The catalyst: BioMarin’s agreement to buy Amicus Therapeutics (NASDAQ: FOLD) for $14.50 per share in cash, valuing the deal at approximately $4.8 billion. BioMarin says the acquisition adds two marketed, growing therapies—Galafold (Fabry disease) and Pombiliti + Opfolda (Pompe disease)—plus U.S. rights to DMX-200 (a Phase 3 kidney-disease asset), while also resolving a key piece
20 December 2025
··
Cisco (CSCO) Stock News, Analyst Forecasts, and 2026 Outlook: What Investors Are Watching on Dec. 20, 2025

Cisco (CSCO) Stock News, Analyst Forecasts, and 2026 Outlook: What Investors Are Watching on Dec. 20, 2025

Cisco Systems, Inc. (NASDAQ: CSCO) is closing out December with renewed attention from Wall Street after a milestone rally that pushed the networking giant back above its dot-com era peak. Shares ended the latest session (Friday, Dec. 19) at $78.42, up 1.91% on the day, after trading between $76.79 and $79.17 with heavy volume. Yahoo Finance+1 The move keeps Cisco within striking distance of the recent record close near $80.25—a level that effectively marked a “full circle” moment for long-time shareholders after more than two decades. Financial Times+1 But the bigger story for investors isn’t just the chart (and it
20 December 2025
··
CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave, Inc. (NASDAQ: CRWV) has snapped back sharply after a bruising second half of 2025, with the AI infrastructure stock jumping about 22.5% in the latest session to around $83, after trading between roughly $70.70 and $84.19 on heavy volume. The move caps a week dominated by two storylines investors keep circling: validation (government and Wall Street endorsements) versus vulnerability (debt, dilution risk, and execution bottlenecks). Here’s what’s driving CoreWeave stock right now—and what matters most heading into 2026. Why CoreWeave stock jumped: Citi’s “Buy” (with a warning label) and the DOE Genesis Mission Citi resumes coverage: bullish rating, lower
20 December 2025
···
National Stock Exchange of India (NSE) Today: Derivatives Reforms, IPO Signals, and Nifty 50 Forecasts as 2026 Approaches

National Stock Exchange of India (NSE) Today: Derivatives Reforms, IPO Signals, and Nifty 50 Forecasts as 2026 Approaches

Mumbai, December 20, 2025 — The National Stock Exchange of India (NSE) is heading into the final stretch of 2025 with a paradox on its hands: benchmarks remain near record territory, but parts of the market are showing signs of fatigue. On the last trading day of the week, the Nifty 50 ended at 25,966.40, up 0.58%, while NSE’s screen also showed GIFT Nifty futures trading higher in early hours on Saturday. NSE India+1 Against that backdrop, the exchange itself is implementing some of the biggest micro-structure tweaks India’s derivatives traders have seen in years—changes that could reshape liquidity, retail
20 December 2025
·
Recursion Pharmaceuticals Stock (RXRX) News and Forecasts for Dec. 20, 2025: TUPELO Trial Data, JPMorgan Upgrade, and What Comes Next

Recursion Pharmaceuticals Stock (RXRX) News and Forecasts for Dec. 20, 2025: TUPELO Trial Data, JPMorgan Upgrade, and What Comes Next

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) heads into the weekend of December 20, 2025 with investors still digesting a fast-moving sequence of catalysts: fresh clinical data for its lead program REC-4881, a notable JPMorgan upgrade, and a burst of unusually heavy trading volume that has kept the stock in the spotlight. Because U.S. markets are closed on Saturday, the most recent trading reference is Friday’s close (Dec. 19, 2025). RXRX last traded around $4.26 after a volatile week that included a one-day surge and a quick pullback. StockAnalysis RXRX stock price action this week: the “upgrade pop” meets reality checks RXRX’s
20 December 2025
···
Trump Media (DJT) Stock Jumps After $6 Billion Fusion Merger Plan: Latest News, Forecasts, and What Investors Are Watching (Dec. 20, 2025)

Trump Media (DJT) Stock Jumps After $6 Billion Fusion Merger Plan: Latest News, Forecasts, and What Investors Are Watching (Dec. 20, 2025)

Trump Media & Technology Group Corp. (NASDAQ: DJT) is ending the week the way it often lives: loudly, unpredictably, and with traders glued to their screens. After announcing a surprise plan to merge with nuclear fusion developer TAE Technologies in a deal valued at more than $6 billion, DJT shares ripped higher on massive volume—turning a social-media stock into (at least on paper) a new way to bet on the race to power the AI era. GlobeNewswire+2StockAnalysis+2 As of the latest close Friday, Dec. 19, 2025, DJT finished at about $16.09, following a two-day surge that featured a roughly +42%
20 December 2025
···
Ferrovial SE Stock (NASDAQ: FER) News and Forecasts for Dec. 20, 2025: Nasdaq-100 Entry, €800M Buyback, Dividend, and the 2026 Outlook

Ferrovial SE Stock (NASDAQ: FER) News and Forecasts for Dec. 20, 2025: Nasdaq-100 Entry, €800M Buyback, Dividend, and the 2026 Outlook

December 20, 2025 — Ferrovial SE (NASDAQ: FER; Spain: FER; Euronext Amsterdam: FER) is ending the week in a very different universe than most “infrastructure” stocks: on Monday, December 22, 2025, the company is set to join the Nasdaq-100, a club better known for megacap tech than toll roads. Reuters+1 That index milestone lands alongside two shareholder-friendly moves that help explain why Ferrovial stock has been under an unusually bright spotlight in December: a new €800 million share repurchase program and a cash dividend scheduled to be paid from December 22. PR Newswire+1 With U.S.-listed shares closing at $66.39 on
20 December 2025
··
NVIDIA Corporation Stock (NVDA) News Today: China H200 Export Review, Intel Investment Cleared, and Fresh 2026 Price Targets

NVIDIA Corporation Stock (NVDA) News Today: China H200 Export Review, Intel Investment Cleared, and Fresh 2026 Price Targets

December 20, 2025 — NVIDIA Corporation stock (NASDAQ: NVDA) is back in the spotlight as a cluster of policy, regulatory, and analyst-driven headlines collide with the company’s already-heated AI narrative. Shares were last indicated around $180.99, up roughly 3.85% from the prior close, after trading between $175.57 and $181.37 on the latest session tracked. That move isn’t happening in a vacuum. Over the past several days, Nvidia has been pulled by three big gravity wells: Below is what’s driving Nvidia stock today, what analysts are forecasting into 2026, and the specific catalysts investors are watching next. The headline moving NVDA:
20 December 2025
·
HYMC Stock News and Forecast: Hycroft Mining’s Silver Drill Results, Insider Buying, and 2026 Catalysts as of Dec. 20, 2025

HYMC Stock News and Forecast: Hycroft Mining’s Silver Drill Results, Insider Buying, and 2026 Catalysts as of Dec. 20, 2025

Hycroft Mining Holding Corporation (Nasdaq: HYMC) has been one of the louder stories in the small-cap mining universe this December—part precious-metals momentum, part corporate-turnaround narrative, and part “watch the filings” stock. As of Dec. 20, HYMC was indicated around $16.42, after an active session range between $15.30 and $17.24, with roughly 4.8 million shares traded in the latest tape update available. Below is a detailed roundup of the most material news, filings, forecasts, and widely circulated analyses shaping HYMC stock right now, along with the key milestones investors are watching into early 2026. HYMC stock today: price action stays hot
20 December 2025
···
Firefly Aerospace Stock (NASDAQ: FLY) News, Forecasts, and Analysis for Dec. 20, 2025

Firefly Aerospace Stock (NASDAQ: FLY) News, Forecasts, and Analysis for Dec. 20, 2025

Firefly Aerospace Inc. (NASDAQ: FLY) is ending the week with the kind of price action that makes both momentum traders and long-term investors sit up straighter in their chairs. As of Saturday, Dec. 20, 2025 (with U.S. markets closed for the weekend), Firefly shares are around $24.65, after a +22.82% surge in Friday’s session and continued after-hours trading activity. StockAnalysis+1 That move didn’t happen in a vacuum. Over the last 10 days, the news flow around Firefly has been a dense cocktail of new analyst coverage, management updates, lunar-mission partnerships, ongoing litigation headlines, and the ever-present question hovering over any
20 December 2025
···
Lamb Weston Stock (NYSE: LW) Sinks After Earnings: Discounting, Margin Pressure, Dividend Hike, and Fresh 2026 Forecasts (20 Dec 2025)

Lamb Weston Stock (NYSE: LW) Sinks After Earnings: Discounting, Margin Pressure, Dividend Hike, and Fresh 2026 Forecasts (20 Dec 2025)

December 20, 2025 — Lamb Weston Holdings, Inc. (NYSE: LW) is having the kind of week investors don’t put on a vision board. After reporting fiscal Q2 2026 results that beat Wall Street expectations on revenue and adjusted earnings, Lamb Weston stock still fell sharply as markets fixated on a tougher message: pricing pressure is still doing push-ups in the background, and the company’s reaffirmed full‑year outlook implies a more challenging second half than many had hoped. Reuters+2TradingView+2 By the latest available quote on December 20, LW traded around $43.94, reflecting the major post‑earnings reset that hit on Friday, December
20 December 2025
···
AST SpaceMobile (ASTS) Stock Surges Ahead of BlueBird 6 Launch: Latest News, Forecasts, and Key Risks for 2026

AST SpaceMobile (ASTS) Stock Surges Ahead of BlueBird 6 Launch: Latest News, Forecasts, and Key Risks for 2026

December 20, 2025 — AST SpaceMobile, Inc. (NASDAQ: ASTS) is back in the spotlight after a sharp move higher into the weekend, fueled by intensifying attention on a near-term satellite launch that investors see as pivotal to the company’s direct-to-smartphone strategy. ASTS last traded around $75.84, up roughly 15% from the prior close, in a session that also saw the stock hit the mid-$76 area intraday. MarketBeat The immediate catalyst is BlueBird 6 (also described as a BlueBird Block-2 satellite), which is slated to ride ISRO’s LVM3 rocket into low Earth orbit. The launch has been widely reported and officially
20 December 2025
··
Nebius Group N.V. (NBIS) Stock News: Blackwell Ultra Launch, Microsoft & Meta Deals, and Wall Street Forecasts (Dec. 20, 2025)

Nebius Group N.V. (NBIS) Stock News: Blackwell Ultra Launch, Microsoft & Meta Deals, and Wall Street Forecasts (Dec. 20, 2025)

Nebius Group N.V. (NASDAQ: NBIS) stock is ending the week with a loud reminder that the “AI infrastructure” trade is still very much alive—and still extremely volatile. Shares jumped roughly 14.6% on Friday, Dec. 19, to around $89.46 after closing near $78 the prior session, with trading volume running above typical levels. MarketBeat That move follows a choppy stretch for “neocloud” names (specialist GPU cloud providers) as investors debate whether the sector’s growth is worth the capital intensity—and debt risk—required to build it. Nebius is sitting right in the blast radius of that debate, because the company is simultaneously (1)
20 December 2025
··
Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

December 20, 2025 — Rocket Lab Corporation (NASDAQ: RKLB) is ending the week with the kind of headline every growth stock dreams about: a record close, a major U.S. national security contract, and renewed investor focus on the company’s longer-term “make-or-break” catalyst—Neutron, its next-generation medium-lift rocket. Shares surged into Friday’s close (the last trading session before today’s weekend), closing at $70.52, up 17.7% on the day and marking a new record. The move followed Rocket Lab’s announcement of its largest contract to date, a prime award tied to the U.S. Space Force’s proliferated missile-warning and missile-defense satellite architecture. MarketWatch+1 Below
20 December 2025
····
Imperial Brands PLC Stock (LSE: IMB) News and Forecast (Dec. 20, 2025): Fitch BBB Call, Buyback Momentum, and 2026 Catalysts

Imperial Brands PLC Stock (LSE: IMB) News and Forecast (Dec. 20, 2025): Fitch BBB Call, Buyback Momentum, and 2026 Catalysts

Imperial Brands PLC shares head into the Dec. 20 weekend with investors focused on three fresh threads: an updated credit view from Fitch, a steady drumbeat of share buybacks under the company’s new £1.45 billion programme, and a forward outlook that still leans heavily on the tobacco cash machine while “next generation products” (NGP) scale from a smaller base. The stock is hovering around the 3,176p area, within a 52-week band that’s stretched roughly from the mid‑2,500s to the low‑3,300s. Investing.com What’s new on Imperial Brands stock as of 20 December 2025 1) Fitch reaffirms ‘BBB’ with a Stable outlook
20 December 2025
·
Lloyds Banking Group (LLOY) Share Price Near 52-Week High: Latest News, Forecasts and 2026 Outlook (20 Dec 2025)

Lloyds Banking Group (LLOY) Share Price Near 52-Week High: Latest News, Forecasts and 2026 Outlook (20 Dec 2025)

As of Saturday, 20 December 2025, Lloyds Banking Group plc (LSE: LLOY) is closing out the year with its share price pressing up against the top of its recent range—after a powerful 12-month run that has put UK bank stocks back on a lot of watchlists. The last market close (Friday, 19 December) puts Lloyds shares at 97.42p, with heavy trading volume and a 52‑week range of roughly 52.44p to 97.74p—meaning the stock has recently flirted with fresh highs for the year. Investing.com+2Investing.com+2 That’s the “what.” The “why” is where it gets interesting: a Bank of England rate cut, a
20 December 2025
··
GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK plc (LSE: GSK; NYSE: GSK) heads into the weekend with a rare “everything-bagel” mix of catalysts: a new U.S. drug-pricing agreement tied to tariff relief, a fresh FDA approval that could reshape severe-asthma dosing schedules, expanding vaccine indications in Europe, and a steady drumbeat of buybacks. For investors tracking GSK stock, the headline isn’t just one event—it’s the way policy, pipeline, and capital returns are colliding in the same two-week window. Because December 20, 2025 is a Saturday, markets are closed. In U.S. trading, GSK’s ADR last closed on Friday, Dec. 19 at $48.61. StockAnalysis Below is a detailed
20 December 2025
···
1 … 9 10 11 12 13 … 41

Stock Market Today

AMD stock bounces 8% after brutal midweek slide — what investors watch before Monday

AMD stock bounces 8% after brutal midweek slide — what investors watch before Monday

8 February 2026
AMD shares jumped 8.28% to $208.44 Friday, rebounding after steep losses earlier in the week. Chip stocks rallied as investors bet on continued AI data center spending by major tech firms. Nvidia rose 7.8%, Broadcom gained 7.1%, and the Philadelphia Semiconductor Index closed up 5.7%. Markets now await macroeconomic data and Nvidia’s late-February results.
Intel stock price jumps to $50: China CPU delays and SambaNova funding set up week ahead

Intel stock price jumps to $50: China CPU delays and SambaNova funding set up week ahead

8 February 2026
Intel shares rose 4.9% to $50.59 Friday, tracking a 5.7% jump in the PHLX semiconductor index as investors bet on AI-driven data-center spending. Reuters reported Intel and AMD warned Chinese customers of tighter server CPU supply, pushing Intel’s China prices up over 10%. Intel expects supply to improve in Q2. After the bell, Reuters said Intel plans to invest about $100 million in AI chip startup SambaNova Systems.
Go toTop